Effects of lipid microspheres prostaglandin E1 injection on the treatment of chronic severe hepatitis.
-
摘要: 探讨凯时注射液 (LipoPGE1)治疗慢性重型肝炎的临床疗效。 6 2例慢性重型肝炎随机分二组 :治疗组(32例 )在综合治疗基础上加LipoPGE12 0 μg/d静脉滴注 ,对照组 (30例 )仅用综合治疗。结果显示治疗组治疗后TBil,TBA ,ALT均明显低于对照组 (P <0 0 1) ,PTA上升明显高于对照组 (P <0 0 1)。治疗组总有效率 (6 5 6 % )明显高于对照组 (36 7% ) (P <0 0 5 )。因此LipoPGE1对慢性重型肝炎治疗有一定疗效Abstract: To study clinical effect of lipid microspheres prostaglandin E1 in treating chronic severe hepatitis. Sixty-two patients with chronic severe hepatitis were randomly divided into treatment group (n=32) and control group (n=30) . On the basis of the comprehensive cure, the treatment group was given lipo-prostaglandin E1 20μg once day. The control group was only given the comprehensive cure, The serum level of TBil, TBA and ALT were more lower in the treatment group than that in the control group (P<0.01) after treatment. PTA was more lower in the treatment group than that in the control group (P<0.01) after treatment. PTA was increased in the treatment group than in the control group (P<0.01) .The total efficacy rate was 65.6% in the treatment group and 36.7% in the control group. They were significantly difference between two group (P<0.05) . It is indeed effective using Lipo PGE1 injection to patients with chronic severe hepatitis.
-
Key words:
- lipo PGE1 /
- chronic severe hepatitis /
- efficacy
-
[1]刘宪玲.前列腺素E1的肝保护作用.国外医学[J].消化系疾病分册, 2000, 20 (3) ∶167. [2]张成平.前列腺素E与肝脏[J].临床肝胆病杂志, 1996, 12∶178. [3]周霞秋, 斯崇文, 王兆全, 等.重型肝炎多中心药物治疗 (附166例临床分析) [J].中华传染病杂志, 1998, 16 (1) ∶45~46
本文二维码
计量
- 文章访问数: 2165
- HTML全文浏览量: 17
- PDF下载量: 763
- 被引次数: 0